Brainstorm Cell Therapeutics Inc (BCLI) — Cash Flow Quality Index

Latest as of December 2017: -10.63x

Brainstorm Cell Therapeutics Inc (BCLI) has a Cash Flow Quality Index of -10.63x as of December 2017. Operating cash flow of $-2.94 Million is below net income of $276.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Brainstorm Cell Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-10.63x

Operating CF / Net Income

Operating Cash Flow

$-2.94 Million

USD

Net Income

$276.00K

USD

Data as of

Dec 2017

Most recent filing

Annual Cash Flow Quality Index for Brainstorm Cell Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Brainstorm Cell Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.